CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −74 | $562.97 | $42K | 333,869 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −110 | $563.98 | $62K | 333,759 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $565.09 | $90K | 333,599 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $570.08 | $91K | 333,439 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $571.77 | $91K | 333,279 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $573.39 | $23K | 333,239 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −130 | $575.32 | $75K | 333,109 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −190 | $576.80 | $110K | 332,919 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $577.28 | $162K | 332,639 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $578.59 | $93K | 332,479 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $579.69 | $93K | 332,319 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $581.03 | $209K | 331,959 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $581.83 | $233K | 331,559 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −760 | $583.09 | $443K | 330,799 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,200 | $584.21 | $701K | 329,599 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,756 | $585.24 | $1.0M | 327,843 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,280 | $586.31 | $750K | 326,563 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −937 | $587.24 | $550K | 325,626 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −783 | $588.19 | $461K | 324,843 |
Page 13 of 64 · 1,267 trades